반응식
[CH3:1][C:2]1[S:6][C:5]2=[N:7][CH:8]=[C:9]([C:10](=[O:12])[CH3:11])[N:4]2[C:3]=1[CH3:13].[C:14]1(C)[CH:19]=[CH:18][CH:17]=[C:16]([S:20]([NH2:23])(=[O:22])=[O:21])[CH:15]=1.[CH:25](=O)[C:26]1[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=1.[C:33]1(C)C(S(Cl)(=O)=O)=CC=CC=1.NC1C=C(C=CC=1)C=O>>[CH3:1][C:2]1[S:6][C:5]2=[N:7][CH:8]=[C:9]([C:10](=[O:12])[CH:11]=[CH:25][C:26]3[CH:31]=[C:30]([C:15]4[CH:14]=[C:19]([CH3:33])[CH:18]=[CH:17][C:16]=4[S:20]([NH2:23])(=[O:21])=[O:22])[CH:29]=[CH:28][CH:27]=3)[N:4]2[C:3]=1[CH3:13]참가 물질
6
실험 절차
1-(2,3-Dimethylimidazo[2,1-b]-thiazol-5-yl ethanone (Formula N′-1), 0.97 g, was condensed with the 3-toluensulfonamide of benzaldehyde, m.p. 126-127°, prepared from toluene sulfonyl chloride and 3-aminobenzaldehyde, according to non-critical modifications of PREPARATION 15 to provide pure (E)-N-[3-[3-(2,3-Dimethylimidazo[2,1-b]thiazol-5-yl)-3-oxo-1-propenyl]phenyl-4-methylbenzenesulfonamide, m.p. 236-237°, Formula N′-2.
후처리
- customaccording to non-critical modifications of PREPARATION 15
출처 및 근거
- ORD 기록
- ord-ed899c7d24cd4a589abc1bab3ad8f41e
- 출처 데이터셋
- uspto-grants-2001_02
- 특허 번호
- US06191124B1
연결된 노트
불러오는 중…